SinoMab BioScience Management
Management criteria checks 2/4
SinoMab BioScience's CEO is Shawn Leung, appointed in Jan 2001, has a tenure of 23.25 years. total yearly compensation is CN¥5.20M, comprised of 99.7% salary and 0.3% bonuses, including company stock and options. directly owns 11.88% of the company’s shares, worth HK$246.49M. The average tenure of the management team and the board of directors is 2.7 years and 4.3 years respectively.
Key information
Shawn Leung
Chief executive officer
CN¥5.2m
Total compensation
| CEO salary percentage | 99.7% |
| CEO tenure | 23.3yrs |
| CEO ownership | 11.9% |
| Management average tenure | 2.7yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Update: SinoMab BioScience (HKG:3681) Stock Gained 21% In The Last Year
Mar 04
What You Need To Know About SinoMab BioScience Limited's (HKG:3681) Investor Composition
Jan 28Did SinoMab BioScience Limited (HKG:3681) Insiders Buy Up More Shares?
Jan 01
Loss-Making SinoMab BioScience Limited (HKG:3681) Expected To Breakeven In The Medium-Term
Nov 30CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -CN¥243m |
| Sep 30 2023 | n/a | n/a | -CN¥259m |
| Jun 30 2023 | n/a | n/a | -CN¥274m |
| Mar 31 2023 | n/a | n/a | -CN¥279m |
| Dec 31 2022 | CN¥5m | CN¥5m | -CN¥284m |
| Sep 30 2022 | n/a | n/a | -CN¥301m |
| Jun 30 2022 | n/a | n/a | -CN¥318m |
| Mar 31 2022 | n/a | n/a | -CN¥303m |
| Dec 31 2021 | CN¥4m | CN¥4m | -CN¥288m |
| Sep 30 2021 | n/a | n/a | -CN¥222m |
| Jun 30 2021 | n/a | n/a | -CN¥156m |
| Mar 31 2021 | n/a | n/a | -CN¥139m |
| Dec 31 2020 | CN¥5m | CN¥4m | -CN¥123m |
Compensation vs Market: Shawn's total compensation ($USD717.36K) is above average for companies of similar size in the Hong Kong market ($USD339.73K).
Compensation vs Earnings: Shawn's compensation has increased whilst the company is unprofitable.
CEO
Shawn Leung (63 yo)
23.3yrs
Tenure
CN¥5,198,000
Compensation
Dr. Shui On Leung, also known as Shawn, serves as Chief Executive Officer of SinoMab BioScience Limited since January 2003 and also serves as its Director and Chairman of the Board since April 27 2001 and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 23.3yrs | CN¥5.20m | 11.88% CN¥ 246.5m | |
| Chief Financial Officer | 5.3yrs | no data | no data | |
| Chief Medical Officer | 2.7yrs | no data | no data | |
| President of China & Executive Director | 2.3yrs | no data | 1.41% CN¥ 29.1m | |
| Company secretary | 1.1yrs | no data | no data |
2.7yrs
Average Tenure
55yo
Average Age
Experienced Management: 3681's management team is considered experienced (2.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 23yrs | CN¥5.20m | 11.88% CN¥ 246.5m | |
| President of China & Executive Director | less than a year | no data | 1.41% CN¥ 29.1m | |
| Independent Non-Executive Director | 4.5yrs | CN¥270.00k | no data | |
| Non-Executive Director | 6.7yrs | no data | no data | |
| Non-Executive Director | 6.7yrs | no data | 4.28% CN¥ 88.8m | |
| Independent Non-Executive Director | 4.5yrs | CN¥270.00k | no data | |
| Non-Executive Director | 4.3yrs | no data | no data | |
| Independent Non Executive Director | 4.3yrs | CN¥270.00k | no data | |
| Independent Non-Executive Director | 2.8yrs | CN¥270.00k | no data | |
| Non-Executive Director | 2.3yrs | no data | no data | |
| Non-Executive Director | less than a year | no data | no data |
4.3yrs
Average Tenure
54yo
Average Age
Experienced Board: 3681's board of directors are considered experienced (4.3 years average tenure).